Literature DB >> 16201933

Cure of multidrug-resistant Acinetobacter baumannii fixation device-related orthopedic infections in two patients with intravenous colistin.

Sofia K Kasiakou1, Kostas Fragoulis, George Tzagarakis, Panagiotis Mistidis, Anastasios Kapaskelis, Matthew E Falagas.   

Abstract

We report our experience with two cases of fixation device-related orthopedic infections due to multidrug-resistant Acinetobacter baumannii strains. Both patients were successfully treated with intravenous administration of colistin, despite the reported poor penetration of this medication to these tissues, in the old literature. No serious colistin-associated toxicity developed and no recurrence of the infection occurred on follow up.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16201933     DOI: 10.1089/mdr.2005.11.287

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Chun-Hong Tan; Jian Li; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

2.  Colistin: the phoenix arises.

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

Review 3.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 4.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

5.  Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa.

Authors:  Deana M Sabuda; Kevin Laupland; Johann Pitout; Bruce Dalton; Harvey Rabin; Thomas Louie; John Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

Review 6.  A new strategy to fight antimicrobial resistance: the revival of old antibiotics.

Authors:  Nadim Cassir; Jean-Marc Rolain; Philippe Brouqui
Journal:  Front Microbiol       Date:  2014-10-20       Impact factor: 5.640

7.  Rapid, simple, and clinically applicable high-performance liquid chromatography method for clinical determination of plasma colistin concentrations.

Authors:  Yuki Hanai; Kazuhiro Matsuo; Takayoshi Kosugi; Ayumu Kusano; Hayato Ohashi; Itsuki Kimura; Shinobu Hirayama; Yuta Nanjo; Yoshikazu Ishii; Takahiro Sato; Taito Miyazaki; Kenji Nishizawa; Takashi Yoshio
Journal:  J Pharm Health Care Sci       Date:  2018-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.